ask="3.00"
ask_size="200"
average_daily_volume="1061120"
bid="2.49"
bid_size="4000"
book_value="-0.03"
change="-0.09"
change_from_200_day_moving_average="0.85"
change_from_50_day_moving_average="0.49"
change_from_52_week_high="-1.39"
change_From_52_week_low="1.50"
change_in_percent="-3.33%"
close="2.61"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.51"
ebitda="-13.34M"
eps_estimate_current_year="-1.23"
eps_estimate_next_quarter="-0.29"
eps_estimate_next_year="-0.44"
ex_dividend_date="N/A"
float_shares="4867000"
high="2.69"
high_52_weeks="4.00"
last_trade_date="3/14/2017"
last_trade_price="2.61"
last_trade_size="399"
last_trade_time="4:00pm"
low="2.55"
low_52_weeks="1.11"
market_capitalization="26.71M"
moving_average_200_day="1.76"
moving_average_50_day="2.12"
name="Eyegate Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="8.00"
open="2.62"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+48.71%"
percent_change_from_50_day_moving_average="+23.06%"
percent_change_from_52_week_high="-34.75%"
percent_change_from_52_week_low="+135.14%"
previous_close="2.70"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="2.75"
price_per_book="N/A"
price_per_sales="41.29"
revenue="669259.00"
shares_outstanding="10234000"
short_ratio="1.02"
stock_exchange="NCM"
symbol="EYEG"
volume="192066"
weeks_range_52="1.11 - 4.00"
